Drug Study

Name of Date Route of General Client’s nursing

drugs administ administra action Indication response to responsibilities
(generic ered tion, Mechanism / med. With prior to,
and brand dosage of action Purpose actual side during, and
name) and effects (if after
frequency any) administration
of
administra
tion
Generic No date Oral route, Metoprolol is Metoprolol CNS: Before:
name: indicated. 50 mg, b.i.d. a beta-1- is a beta dizziness,  Do not use
Metoprolol adrenergic blocker vertigo, this
Initial dose: receptor that works stroke, medication if
Brand 100 mg inhibitor that by headache patient is
Name: orally per only affects preventing allergic to
Lopressor, day in single cardiac cells certain Cardiovascula metoprolol or
Toprol-XL or divided and has no natural r: Heart other beta-
doses impact on substances failure, blockers or
Drug beta-2 in your hypotension, patient has:
Classificati receptors. body, such bradycardia
on: Maintenanc This as  Serious heart
Beta- e dose: 100 inhibition epinephrine GI: diarrhea, problem
blockers to 450 mg reduces , from nausea, dry  Severe
orally per cardiac acting on mouth, gastric circulation
day output by your heart pain, problems
causing and blood constipation,  Severe heart
negative arteries. flatulence, failure
chronotropic This abdominal  A history of
and inotropic impact pain, slow
effects while reduces vomiting heartbeats
exhibiting heart rate,
neither blood Skin: mild During:
activity pressure, itching or rash  Take
toward and cardiac metoprolol
membrane strain. Respiratory: exactly as
stability nor Shortness of prescribed.
intrinsic breath, Follow
sympathomi wheezing, prescription
metic. dyspnea label.
 Take the
Other:
medicine at
tiredness,
the same time
peripheral
each day
edema,
 Metoprolol
fatigue
should be
taken with a
meal or just
after a meal.
 Swallow
tablet, do not
chew, crush,
break, or
open it.

After:
 Monitor
Blood
pressure,
ECG, and
pulse
frequently
during dose
adjustments
and
periodically
during
therapy.
 Monitor vital
signs and
ECH every 5-
15 miutes
during and
after several
hours after
parenteral
administratio
n.
 Monitor
intake and
output ratios,
and daily
weighs
 Assess
routinely for
signs and
symptoms of
heart failure,
dyspnea,
rales/crackle,
weight gain,
peripheral
edema, and
jugular vein
distention.